Peter Borden

Peter Borden is an experienced director specializing in corporate strategy, currently serving at AbbVie since November 2021. Prior to this, Peter worked as a project leader and consultant at Boston Consulting Group from July 2019 to October 2021, managing teams and developing strategic solutions for prominent pharmaceutical, medtech, and consumer goods companies. Notably, Peter has a strong background in biopharma and medtech, where accomplishments include developing a $50 million manufacturing strategy and a $1 billion acquisition strategy in the diabetes sector. Additionally, Peter has expertise in marketing, sales, and pricing, having driven significant revenue increases for a global consumer goods retailer. Academically, Peter obtained a PhD in Biomedical/Medical Engineering from the Georgia Institute of Technology, complemented by undergraduate research in bioengineering at Rice University.